社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
ImmunityBio, Inc.(IBRX)
6.47
+0.95
+17.12%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
ImmunityBio, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.immunitybio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。
01-20 13:00
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
01-16
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
01-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-24
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-05
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-05
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-25
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-06-23
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-06-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
7.98
今开
6.55
量比
3.76
最低
6.08
昨收
5.52
换手率
93.24%
热议股票
{"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"IBRX","data":{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":6.465,"timestamp":1768935242106,"preClose":5.52,"halted":0,"volume":180890839,"delay":0,"changeRate":0.1711956521739131,"floatShares":194000000,"shares":984965179,"eps":-0.415322,"marketStatus":"交易中","change":0.945,"latestTime":"01-20 13:54:02 EST","open":6.55,"high":7.98,"low":6.08,"amount":1259566518.2114894,"amplitude":0.344203,"askPrice":6.47,"askSize":831,"bidPrice":6.46,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-0.415322,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768942800000},"marketStatusCode":2,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":5.52,"preHourTrading":{"tag":"盘前","latestPrice":6.51,"preClose":5.52,"latestTime":"09:29 EST","volume":9974302,"amount":63698709.3148848,"timestamp":1768919399797,"change":0.99,"changeRate":0.179348,"amplitude":0.393116},"postHourTrading":{"tag":"盘后","latestPrice":6.0408,"preClose":5.52,"latestTime":"19:59 EST","volume":6775692,"amount":39964111.8995,"timestamp":1768611598601,"change":0.5208,"changeRate":0.094348,"amplitude":0.20721},"volumeRatio":3.763312,"optionData":{"bulkOrders":[{"symbol":"IBRX","call":true,"expireDate":1832043600000,"strike":"3.5","timestamp":1768927477284,"price":4.52,"volume":10000,"amount":4520000,"type":"-"}]},"impliedVol":2.5597,"impliedVolPercentile":0.9801},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20645615","market":"us","labels":[],"media":"sec.gov","original_id":"AN194984626000009-IBRX","pdf_url":"","pub_time":1768885200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000194984626000009/0001949846-26-000009-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000194984626000009/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEBQ1RcaLnuvpBRMYW","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-01-20 13:00","pubTimestamp":1768885200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"20640443","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726000516-IBRX","pdf_url":"","pub_time":1768539600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"IBRX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726000516/0001950047-26-000516-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000195004726000516/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE29sYHh4ZUWKwQXh7","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-01-16 13:00","pubTimestamp":1768539600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20635254","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000008-IBRX","pdf_url":"","pub_time":1768453200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/0001326110-26-000008-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20261158xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-20261158xkexhibit991.htm","type":"EX-99.1","id":"NTFILE7jtw7uEqSXtTSYRT","market":"us","size":21400},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/ibrx-20260115.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260115.htm","type":"8-K","id":"NTFILEBH1pVydd1iKSGNRL","market":"us","size":30539},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000008/immunitybio-logox2024xcoloa.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcoloa.jpg","type":"GRAPHIC","id":"NTFILE5U3prMBFJxaPtTEg","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-15 13:00","pubTimestamp":1768453200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20631592","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611026000004-IBRX","pdf_url":"","pub_time":1768366800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/0001326110-26-000004-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20261148xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-20261148xkexhibit991.htm","type":"EX-99.1","id":"NTFILEFcSgW4shVXcsfx63","market":"us","size":22145},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20260114.htm","primary":false,"translateUrl":"","linkName":"ibrx-20260114.htm","type":"8-K","id":"NTFILEB5q1TYYVGNpVDRSj","market":"us","size":33306},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/ibrx-20261148xkexhibit992.htm","primary":false,"translateUrl":"","linkName":"ibrx-20261148xkexhibit992.htm","type":"EX-99.2","id":"NTFILE2B5sy7CN2D5n2Fvc","market":"us","size":22612},{"description":"IMMUNITYBIO LOGO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/immunitybio-logox2024xcoloa.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcoloa.jpg","type":"GRAPHIC","id":"NTFILEAfV9JyXWjPx75qXU","market":"us","size":31902},{"description":"IMMUNITYBIO LOGO","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611026000004/immunitybio-logox2024xcolob.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcolob.jpg","type":"GRAPHIC","id":"NTFILEDyZBDVsCncr2fsC9","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-14 13:00","pubTimestamp":1768366800,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20580199","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525331244-IBRX","pdf_url":"","pub_time":1766535940000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001193125-25-331244-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex31.htm","primary":true,"translateUrl":"","linkName":"d61833dex31.htm","type":"EX-3.1","id":"NTFILE5wn9Q63ra72RhjHU","market":"us","size":5815},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833d8k.htm","primary":false,"translateUrl":"","linkName":"d61833d8k.htm","type":"8-K","id":"NTFILE3d9pjERon5F1on9x","market":"us","size":32268},{"description":"EX-5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex51.htm","primary":false,"translateUrl":"","linkName":"d61833dex51.htm","type":"EX-5.1","id":"NTFILE99BfwEG3xoeByXRQ","market":"us","size":9107},{"description":"EX-10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/d61833dex101.htm","primary":false,"translateUrl":"","linkName":"d61833dex101.htm","type":"EX-10.1","id":"NTFILE7zNG17bKojG1yY8N","market":"us","size":14520},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525331244/g61833g1223191314206.jpg","primary":false,"translateUrl":"","linkName":"g61833g1223191314206.jpg","type":"GRAPHIC","id":"NTFILE86JjTW2UH1EDimQs","market":"us","size":3107}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-24 08:25","pubTimestamp":1766535940,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20536193","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000146-IBRX","pdf_url":"","pub_time":1765833953000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/0001326110-25-000146-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000146/ibrx-20251210.htm","primary":true,"translateUrl":"","linkName":"ibrx-20251210.htm","type":"8-K","id":"NTFILE6CzpzHSQpXYNAyHd","market":"us","size":32964}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-16 05:25","pubTimestamp":1765833953,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20525570","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000143-IBRX","pdf_url":"","pub_time":1765515600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/0001326110-25-000143-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/ibrx-202512128xkexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-202512128xkexhibit991.htm","type":"EX-99.1","id":"NTFILEB5yJ4fNaqfqqVwK7","market":"us","size":24293},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/ibrx-20251212.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251212.htm","type":"8-K","id":"NTFILEAyUjHmMNFuHqC7bF","market":"us","size":28173},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000143/immunitybio-logox2024xcolo.jpg","primary":false,"translateUrl":"","linkName":"immunitybio-logox2024xcolo.jpg","type":"GRAPHIC","id":"NTFILEFDzpSeZWPCBUZPPs","market":"us","size":31902}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-12 13:00","pubTimestamp":1765515600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20371815","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000138-IBRX","pdf_url":"","pub_time":1762318800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/0001326110-25-000138-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/ibrx-2025114x8kexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-2025114x8kexhibit991.htm","type":"EX-99.1","id":"NTFILEGdK2TmNKEiv1ZdUk","market":"us","size":130959},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/ibrx-20251104.htm","primary":false,"translateUrl":"","linkName":"ibrx-20251104.htm","type":"8-K","id":"NTFILE2Vs52nXkAsFR7Tep","market":"us","size":30854},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000138/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILE7WUdgmtrtNEUD5v2","market":"us","size":2549}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-05 13:00","pubTimestamp":1762318800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20371801","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000139-IBRX","pdf_url":"","pub_time":1762318800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"IBRX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/0001326110-25-000139-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-20250930.htm","primary":true,"translateUrl":"","linkName":"ibrx-20250930.htm","type":"10-Q","id":"NTFILED3qt9N3AECYVqGfX","market":"us","size":3282741},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit311.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit311.htm","type":"EX-31.1","id":"NTFILEF6npygf8KB3CMTL9","market":"us","size":11147},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit312.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit312.htm","type":"EX-31.2","id":"NTFILECkYvchTytivrjJ6o","market":"us","size":10915},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit321.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit321.htm","type":"EX-32.1","id":"NTFILEGticmPyxN73vEDpY","market":"us","size":5206},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-2025930x10qexhibit322.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025930x10qexhibit322.htm","type":"EX-32.2","id":"NTFILE7JmRACFFQZVL3R6L","market":"us","size":4951},{"description":"2025 PIPELINE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000139/ibrx-20250930_g1.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20250930_g1.jpg","type":"GRAPHIC","id":"NTFILEEo5m59DdPcpPo9Xz","market":"us","size":174354}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-05 13:00","pubTimestamp":1762318800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19967167","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525177024-IBRX","pdf_url":"","pub_time":1754625600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/0001193125-25-177024-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/d29656dex991.htm","primary":true,"translateUrl":"","linkName":"d29656dex991.htm","type":"EX-99.1","id":"NTFILED5KSa3m4BLTVx17B","market":"us","size":61450},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/d29656d8k.htm","primary":false,"translateUrl":"","linkName":"d29656d8k.htm","type":"8-K","id":"NTFILE4kFMg5zwF1S5rust","market":"us","size":27638},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/d29656dex992.htm","primary":false,"translateUrl":"","linkName":"d29656dex992.htm","type":"EX-99.2","id":"NTFILE3oACJxqDoTM4uU4A","market":"us","size":349958}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-08 12:00","pubTimestamp":1754625600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19948621","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000114-IBRX","pdf_url":"","pub_time":1754366400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"IBRX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/0001326110-25-000114-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-20250630.htm","primary":true,"translateUrl":"","linkName":"ibrx-20250630.htm","type":"10-Q","id":"NTFILEFr8EQgkABExbVmxH","market":"us","size":3099481},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-2025630x10qexhibit311.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025630x10qexhibit311.htm","type":"EX-31.1","id":"NTFILEh3dQgd56nDShFt3J","market":"us","size":11145},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-2025630x10qexhibit312.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025630x10qexhibit312.htm","type":"EX-31.2","id":"NTFILE8LgNB5UNDuSYJqMn","market":"us","size":10913},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-2025630x10qexhibit321.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025630x10qexhibit321.htm","type":"EX-32.1","id":"NTFILE6undGeb1cqCYgoGY","market":"us","size":5199},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-2025630x10qexhibit322.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025630x10qexhibit322.htm","type":"EX-32.2","id":"NTFILEEwKx89DCGUK2rx8v","market":"us","size":4944},{"description":"2025 PIPELINE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000114/ibrx-20250630_g1.jpg","primary":false,"translateUrl":"","linkName":"ibrx-20250630_g1.jpg","type":"GRAPHIC","id":"NTFILEEUDWtyPuMAKErzqW","market":"us","size":174354}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-05 12:00","pubTimestamp":1754366400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19948541","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000112-IBRX","pdf_url":"","pub_time":1754366400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000112/0001326110-25-000112-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000112/ibrx-202585x8kexhibit991.htm","primary":true,"translateUrl":"","linkName":"ibrx-202585x8kexhibit991.htm","type":"EX-99.1","id":"NTFILE4kntRPbcmVrXJeST","market":"us","size":132238},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000112/ibrx-20250805.htm","primary":false,"translateUrl":"","linkName":"ibrx-20250805.htm","type":"8-K","id":"NTFILECHAyECfDv6jKjC2u","market":"us","size":30635},{"description":"IMMUNITYBIO LOGO","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000112/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILEHLWxZHnhRTDAS46f","market":"us","size":2549}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-05 12:00","pubTimestamp":1754366400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19911145","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312525164789-IBRX","pdf_url":"","pub_time":1753416000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/0001193125-25-164789-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-1.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex11.htm","primary":true,"translateUrl":"","linkName":"d20571dex11.htm","type":"EX-1.1","id":"NTFILEYZSND3nqXxwjiesV","market":"us","size":157081},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571d8k.htm","primary":false,"translateUrl":"","linkName":"d20571d8k.htm","type":"8-K","id":"NTFILE3t7w5pwWhVq7YzNt","market":"us","size":39098},{"description":"EX-4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex41.htm","primary":false,"translateUrl":"","linkName":"d20571dex41.htm","type":"EX-4.1","id":"NTFILEV79dLzH4ysXCgN45","market":"us","size":79965},{"description":"EX-5.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex51.htm","primary":false,"translateUrl":"","linkName":"d20571dex51.htm","type":"EX-5.1","id":"NTFILEAHo536N99L86SxeY","market":"us","size":15445},{"description":"EX-10.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex101.htm","primary":false,"translateUrl":"","linkName":"d20571dex101.htm","type":"EX-10.1","id":"NTFILEHtM9Piwgxa1tP8gc","market":"us","size":167138},{"description":"EX-99.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex991.htm","primary":false,"translateUrl":"","linkName":"d20571dex991.htm","type":"EX-99.1","id":"NTFILE4fsYG56rEhGwttk2","market":"us","size":28768},{"description":"EX-99.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/d20571dex992.htm","primary":false,"translateUrl":"","linkName":"d20571dex992.htm","type":"EX-99.2","id":"NTFILE4avYMYs2fpzU1f1d","market":"us","size":12245},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/g20571dsp12.jpg","primary":false,"translateUrl":"","linkName":"g20571dsp12.jpg","type":"GRAPHIC","id":"NTFILE3suETpybmspXdBLM","market":"us","size":5134},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525164789/g20571g0505105549782.jpg","primary":false,"translateUrl":"","linkName":"g20571g0505105549782.jpg","type":"GRAPHIC","id":"NTFILE6HAbpUcsgh3mecCN","market":"us","size":3130}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-25 12:00","pubTimestamp":1753416000,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目2.02：经营业绩和财务状况；第7.01项：法规FD披露；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19799549","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000099-IBRX","pdf_url":"","pub_time":1750651200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"IBRX","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000099/0001326110-25-000099-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000099/ibrx-2025623xs8.htm","primary":true,"translateUrl":"","linkName":"ibrx-2025623xs8.htm","type":"S-8","id":"NTFILEBZ3YBxgPCydxxr2B","market":"us","size":96996},{"description":"EXHIBIT 107","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000099/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILE7ZFtHopXy3ofNbPZ","market":"us","size":23721},{"description":"EX-5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000099/ibrx-2025623xs8exhibit51.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025623xs8exhibit51.htm","type":"EX-5.1","id":"NTFILE9cNSeWobfDS6Ygo4","market":"us","size":10439},{"description":"EX-23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000099/ibrx-2025x623xs8exhibit231.htm","primary":false,"translateUrl":"","linkName":"ibrx-2025x623xs8exhibit231.htm","type":"EX-23.1","id":"NTFILEGyaHGkZPH3yN8uL2","market":"us","size":2106}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-06-23 12:00","pubTimestamp":1750651200,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19794231","market":"us","labels":[],"media":"sec.gov","original_id":"AN132611025000084-IBRX","pdf_url":"","pub_time":1750392000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"IBRX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000084/0001326110-25-000084-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000084/ibrx-2025620x8xkexhibit101.htm","primary":true,"translateUrl":"","linkName":"ibrx-2025620x8xkexhibit101.htm","type":"EX-10.1","id":"NTFILE62pCEFAhMWeHmY51","market":"us","size":207231},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000084/ibrx-20250618.htm","primary":false,"translateUrl":"","linkName":"ibrx-20250618.htm","type":"8-K","id":"NTFILE7qyF48qxCKEvjsyj","market":"us","size":56110}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-20 12:00","pubTimestamp":1750392000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目5.07：将事项提交证券持有人表决；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":1.3691},{"period":"1month","weight":1.6161},{"period":"3month","weight":1.3},{"period":"6month","weight":1.0073},{"period":"1year","weight":0.8158},{"period":"ytd","weight":1.7879}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.185635},{"month":2,"riseRate":0.5,"avgChangeRate":0.026818},{"month":3,"riseRate":0.3,"avgChangeRate":-0.083879},{"month":4,"riseRate":0.5,"avgChangeRate":0.021643},{"month":5,"riseRate":0.4,"avgChangeRate":0.054052},{"month":6,"riseRate":0.3,"avgChangeRate":0.132356},{"month":7,"riseRate":0.4,"avgChangeRate":-0.029239},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.110134},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.03348},{"month":10,"riseRate":0.454545,"avgChangeRate":0.029893},{"month":11,"riseRate":0.636364,"avgChangeRate":0.121867},{"month":12,"riseRate":0.363636,"avgChangeRate":0.048951}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"aProfile":null}}}